These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34818230)

  • 41. Developmental activation of the capability to undergo checkpoint-induced apoptosis in the early zebrafish embryo.
    Ikegami R; Hunter P; Yager TD
    Dev Biol; 1999 May; 209(2):409-33. PubMed ID: 10328930
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Global profiling of DNA replication timing and efficiency reveals that efficient replication/firing occurs late during S-phase in S. pombe.
    Eshaghi M; Karuturi RK; Li J; Chu Z; Liu ET; Liu J
    PLoS One; 2007 Aug; 2(8):e722. PubMed ID: 17684567
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gimatecan and other camptothecin derivatives poison Leishmania DNA-topoisomerase IB leading to a strong leishmanicidal effect.
    Prada CF; Alvarez-Velilla R; Balaña-Fouce R; Prieto C; Calvo-Álvarez E; Escudero-Martínez JM; Requena JM; Ordóñez C; Desideri A; Pérez-Pertejo Y; Reguera RM
    Biochem Pharmacol; 2013 May; 85(10):1433-40. PubMed ID: 23466420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Computational workflow for integrative analyses of DNA replication timing, epigenomic, and transcriptomic data.
    Ji F; Van Rechem C; Whetstine JR; Sadreyev RI
    STAR Protoc; 2022 Dec; 3(4):101827. PubMed ID: 36386876
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Importance of replication fork progression for the induction of chromosome damage and SCE by inhibitors of DNA topoisomerases.
    Cortés F; Piñero J; Ortiz T
    Mutat Res; 1993 Oct; 303(2):71-6. PubMed ID: 7692280
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The cell cycle effects of camptothecin.
    Darzynkiewicz Z; Bruno S; Del Bino G; Traganos F
    Ann N Y Acad Sci; 1996 Dec; 803():93-100. PubMed ID: 8993503
    [No Abstract]   [Full Text] [Related]  

  • 47. Topoisomerase degradation, DSB repair, p53 and IAPs in cancer cell resistance to camptothecin-like topoisomerase I inhibitors.
    Tomicic MT; Kaina B
    Biochim Biophys Acta; 2013 Jan; 1835(1):11-27. PubMed ID: 23006513
    [TBL] [Abstract][Full Text] [Related]  

  • 48. S-phase population analysis does not correlate with the cytotoxicity of camptothecin and 10,11-methylenedioxycamptothecin in human colon carcinoma HT-29 cells.
    O'Connor PM; Nieves-Neira W; Kerrigan D; Bertrand R; Goldman J; Kohn KW; Pommier Y
    Cancer Commun; 1991 Aug; 3(8):233-40. PubMed ID: 1653585
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Topoisomerase inhibitors can selectively interfere with different stages of simian virus 40 DNA replication.
    Snapka RM
    Mol Cell Biol; 1986 Dec; 6(12):4221-7. PubMed ID: 3025645
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Protocol for Genome-Wide Analysis of DNA Replication Timing in Intact Root Tips.
    Mickelson-Young L; Wear EE; Song J; Zynda GJ; Hanley-Bowdoin L; Thompson WF
    Methods Mol Biol; 2022; 2382():29-72. PubMed ID: 34705232
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recql5 plays an important role in DNA replication and cell survival after camptothecin treatment.
    Hu Y; Lu X; Zhou G; Barnes EL; Luo G
    Mol Biol Cell; 2009 Jan; 20(1):114-23. PubMed ID: 18987339
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors.
    Bertrand R; Solary E; Jenkins J; Pommier Y
    Exp Cell Res; 1993 Aug; 207(2):388-97. PubMed ID: 7688316
    [TBL] [Abstract][Full Text] [Related]  

  • 53. De novo identification of replication-timing domains in the human genome by deep learning.
    Liu F; Ren C; Li H; Zhou P; Bo X; Shu W
    Bioinformatics; 2016 Mar; 32(5):641-9. PubMed ID: 26545821
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Topoisomerase I inhibitors: camptothecins and beyond.
    Pommier Y
    Nat Rev Cancer; 2006 Oct; 6(10):789-802. PubMed ID: 16990856
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How Trypanosoma cruzi handles cell cycle arrest promoted by camptothecin, a topoisomerase I inhibitor.
    Zuma AA; Mendes IC; Reignault LC; Elias MC; de Souza W; Machado CR; Motta MC
    Mol Biochem Parasitol; 2014 Feb; 193(2):93-100. PubMed ID: 24530483
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of human neurotropic virus (JCV) DNA replication in glial cells by camptothecin.
    Kerr DA; Chang CF; Gordon J; Bjornsti MA; Khalili K
    Virology; 1993 Oct; 196(2):612-8. PubMed ID: 8396804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of DNA synthesis and DNA fragmentation in stimulated splenocytes by the concerted action of topoisomerase I and II poisons.
    Taudou G; Portemer C; Jaxel C; Duguet M
    Biochem Pharmacol; 1993 Jan; 45(2):331-7. PubMed ID: 8382059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sequencing newly replicated DNA reveals widespread plasticity in human replication timing.
    Hansen RS; Thomas S; Sandstrom R; Canfield TK; Thurman RE; Weaver M; Dorschner MO; Gartler SM; Stamatoyannopoulos JA
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):139-44. PubMed ID: 19966280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The concentration-dependent diversity of effects of DNA topoisomerase I and II inhibitors on the cell cycle of HL-60 cells.
    Del Bino G; Skierski JS; Darzynkiewicz Z
    Exp Cell Res; 1991 Aug; 195(2):485-91. PubMed ID: 1649059
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of camptothecin on mitogenic stimulation of human lymphocytes: involvement of DNA topoisomerase I in cell transition from G0 to G1 phase of the cell cycle and in DNA replication.
    Bruno S; Giaretti W; Darzynkiewicz Z
    J Cell Physiol; 1992 Jun; 151(3):478-86. PubMed ID: 1338332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.